ReShape Lifesciences (RSLS) director Minocherhomjee received 253,429 shares
Insider transactions reported
Arda Phd Minocherhomjee (director at ReShape Lifesciences Inc., RSLS) reported that they received 253,429 shares on Jul 22, 2021. After these transactions the filing shows 253,429 shares held directly.
- Reporting person
- Minocherhomjee Arda Phd
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Jul 22, 2021 | Grant or award (A) | Common Stock, $0.001 par value per share1 | +253,429 | - | - | 253,429 direct |
Holdings before and after
- Common Stock, $0.001 par value per share: 0 to 253,429 direct
Footnotes from the filing
- 1. These shares will vest and be issued with respect to 241,961 shares on each of July 22, 2021 and July 22, 2022 pursuant to a restricted stock unit granted under the ReShape Lifesciences Inc. Second Amended and Restated 2003 Stock Incentive Plan.
Transaction codes in this filing
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Minocherhomjee report in this RSLS Form 4?
Arda Phd Minocherhomjee (director at ReShape Lifesciences Inc., RSLS) reported that they received 253,429 shares on Jul 22, 2021. After these transactions the filing shows 253,429 shares held directly.
How many RSLS shares does Minocherhomjee hold after this filing?
The filing shows 253,429 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code A mean on an SEC Form 4?
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
Historical context for RSLS
Earlier insider filings at RSLS
Keep researching RSLS
- RSLS insider tradesEvery buy and sale reported by ReShape Lifesciences Inc. officers, directors and large holders.
- What is Form 4?The SEC filing that reports a change in an insider's holdings, such as a purchase, sale, option exercise or grant, generally within two business days.
- Form 4 explainedForm 4 is the SEC filing that discloses when officers, directors and 10% owners buy or sell company stock, due within 2 business days. Learn every key field and code.
- Insider trading trackerThe latest insider buys and sales across every stock.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- Listed since
- 2016
Follow RSLS and get a push notification the moment its next story breaks.